whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death

June 2012

Please see the March 2013 FDA statement concerning the risk QT interval prolongation with Azithromycin

You'll hear new concerns about whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death.

Erythromycin and clarithromycin can prolong the QT interval and cause fatal arrhythmias (torsades).

Now azithromycin is also associated with a small risk...especially in patients with heart disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote